Trade BioNTech ^BNTX

Virtu Financial LLC Has $1.07 Million Stake in BioNTech SE Sponsored ADR $BNTX - Markets Daily

Virtu Financial LLC Has $1.07 Million Stock Position in BioNTech SE Sponsored ADR $BNTX - Stock Observer

Moderna (MRNA) Eyes Manufacturing Facilities in Germany Amid BioNTech Closures

BioNTech (BNTX) Stock Valuation Questioned As Popular Narrative Signals Large Upside Potential

Moderna suing Pfizer for patent infringement in COVID-19 vaccine

Moderna: BioNTech is claiming work 'it never did'

mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models

Is BioNTech SE (BNTX) A Good Stock To Buy Now?

Promising Biotech Stocks To Watch Today - June 11th - Daily Political

How New Lung Cancer Data for Pumitamig Could Reshape BioNTech's (BNTX) Post-Vaccine Investment Story

BioNTech (BNTX) and Bristol Myers Share New Results From ROSETTA Lung-02 Study

Havemeyer Place LP Takes Position in BioNTech SE Sponsored ADR $BNTX - Daily Political

BioNTech SE Sponsored ADR $BNTX Shares Sold by Capital International Inc. CA

CenterBook Partners LP Grows Holdings in BioNTech SE Sponsored ADR $BNTX - Daily Political

Analysts' Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Fractyl Health, Inc. (GUTS) and BioNTech SE (BNTX)

Assessing BioNTech (BNTX) Valuation After Recent Share Price Weakness And Bold $499 Fair Value Narrative

Recent Analysts' Ratings Updates for BioNTech (BNTX) - Daily Political

How Investors May Respond To BioNTech (BNTX) Showcasing Late-Stage Oncology Data At ASCO

BNTX: Leadership Upheaval And Oncology Trial Risks Will Pressure Expectations

BioNTech (NASDAQ:BNTX) Earns Buy Rating from Jefferies Financial Group

BioNTech (NASDAQ:BNTX) Receives "Buy" Rating from Jefferies Financial Group - Stock Observer

Monaco Asset Management SAM Takes Position in BioNTech SE Sponsored ADR $BNTX

BMY: Promising Phase 2 Results for Pumitamig in Lung Cancer Treatment

How Is Pfizer's Stock Performance Compared to Other Healthcare Stocks?

BNP Paribas Financial Markets Raises Stock Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial | Valuespectrum.com

BioNTech Board Expansion Signals Focus On Oncology Execution And Valuation Gap

BNTX Upgraded by UBS -- Price Target Raised to $135

BioNTech (BNTX) Valuation Check After New Late Stage Oncology Data At 2026 ASCO Meeting

LME to Permanently Restrict Large Positions Amidst Low Inventory

The Future of Payments: Fragmentation, Digital Assets, and AI

Daily Market Review and Trend Analysis: October 22

Crypto Cities: Challenges and Opportunities for a Decentralized Future

OpenAI's Atlas Browser: A Glimpse into the Future of AI Agents on the Web

Precious Metals Retreat Amid Easing Trade Tensions and Rate Cut Expectations

Australian Gold Rush: Record Prices Spark Queues and Investment Debate

Join markets.com and Bryan Habana at Finance Magnates Africa Summit 2023!